#pregnancy

Between 2004 and 2014, African-American women in South Carolina were less likely to receive guideline-based treatment.

New CDC campaign educates cisgender women about PrEP for HIV prevention.

Whether or not they want kids, access to accurate information and the tools to conceive—or not—are essential for people living with HIV.

CDC encourages all pregnant people or people who are thinking about becoming pregnant and those breastfeeding to get vaccinated.

Preterm birth and low birthweights were more common among infants born to women with HIV, but the infants were no more likely to die.

The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.

Right now, it typically takes six years after an HIV drug is approved to obtain data for pregnant people.

A survey of Black women with HIV found that national policy and cultural beliefs contributed to whether they reported breastfeeding.

The Well Project interviews Destiny Smith, Community Advisory Board member, for our “Spotlight: Women Making a Difference” series.

However, it’s still unclear whether Undetectable = Untransmittable extends to breastmilk.

The Department of Health and Human Services has updated its HIV treatment and prevention guidelines for pregnant people and their infants.

A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.

Study results confirm that dolutegravir is a safe and effective treatment for pregnant women with HIV.

But new data add to the evidence that mother-to-infant transmission of the coronavirus appears to be rare.

The findings highlight an ongoing need for better integration of HIV care with sexual and reproductive health care.

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.